The data indicate that HF therapy leads to cell cycle arrest and death via activating the TGF‐β signaling pathway, which is mediated by elevated levels of TGF‐β1, phosphorylation of Smad 3, and expression of TGF‐βRII. This evidence concerns the gene TGFB1 and hydrops fetalis.